Varicella zoster virus immune globulin, also known as VZV globulin, VZV antibodies, zoster immunoglobulin, or by the brand names Vzig and Varizig, is an immune system medication used mainly for immunosuppressed patients who have been or may have been exposed to the varicella zoster virus. It can shorten the duration of skin manifestations of the infection and may help prevent the disease from spreading to other parts of the body, though the protection it provides is passive and temporary, sometimes requiring readministration every two to four weeks. It differs from zoster vaccines, which confer durable immunity, and it is not advised for use in people with normal immune function to treat active disease.
Facts
Connections
Treats
Source VZV Immune Globulin (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/VZV_immune_globulin, lead sectionQuote, https://en.wikipedia.org/wiki/VZV_immune_globulin, lead section
In medicine, varicella zoster virus globulin, VZV antibodies, zoster immunoglobulin (ZIG), varicella zoster immune globulin, is an immune system medication that is used mostly for immunosuppressed patients who have been or may be exposed to the varicella zoster virus (VZV).
View the Source VZV Immune Globulin (Wikipedia)
WikipediaLead section, opening definition
In medicine, varicella zoster virus globulin (VZV globulin), VZV antibodies, zoster immunoglobulin (ZIG), varicella zoster immune globulin (Vzig or Varizig), is an immune system medication that is used mostly for immunosuppressed patients who have been or may be exposed to the varicella zoster virus (VZV).
Treats: Chickenpox, Details section, protection against severe chickenpox in immunosuppressed children
Another study published in The Journal of Infectious Diseases proved that varicella zoster immune globulin (VZIG) can be administered to children with suppressed immune systems to protect them against severe chicken pox.
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.